...
机译:使用生理基于生理学药代动力学建模和模拟的个体患者奥氮平暴露的预测
Department of Clinical PharmacologyFlinders UniversityAdelaide SA Australia;
Medicine and Biomedical Sciences (Emeritus)University of SheffieldSheffield UK;
Department of Clinical PharmacologyFlinders UniversityAdelaide SA Australia;
School of Pharmacy and Medical SciencesUniversity of South AustraliaAdelaide SA Australia;
Department of PsychiatryFlinders Medical CentreAdelaide SA Australia;
Certara Blades Enterprise CentreSheffield UK;
Department of Pharmacology Faculty of ScienceMahidol UniversityBangkok Thailand;
Clinical Pharmacology and Pharmacometrics Early Clinical and Translational ResearchBristol Myers;
Department of Clinical PharmacologyFlinders UniversityAdelaide SA Australia;
dose prediction; olanzapine; PBPK; personalized medicine; physiologically based pharmacokinetics;
机译:基于生理学的药代动力学建模和模拟预测奥氮平个体患者的暴露
机译:基于物理学上的基于物理学的药代动力学建模预测奥氮滨和酶鼠组合在儿科对象中的组合施用时
机译:基于生理学的药代动力学建模,CYP3A4和CYP1A2抑制或诱导组合为ALKS 3831作为ALKS 3831
机译:基于生理学的药代动力学模型预测不同人群中拟除虫菊酯的内部暴露
机译:开发患者特定人群的药代动力学模型并比较隔室与非隔室分析,以预测各个药代动力学参数。
机译:基于生理学的药代动力学建模和模拟预测奥氮平个体患者的暴露
机译:朝向梅罗宁全身和感染现场暴露预测的通用工具:肺炎的成人患者的生理基础药代动力学模型
机译:开发基于生理学的药代动力学/药效学(pBpK / pD)minipig模型模拟低水平多路CW剂暴露